SE8300577L - Overdrag som tillforsekrar reglerad avgivning av akriva bestandsdelar fran biologiskt aktiva blandningar, i synnerhet farmaceutiska beredningar, jemte sett att framstella biologiskt aktiva blandningar med reglerad .... - Google Patents
Overdrag som tillforsekrar reglerad avgivning av akriva bestandsdelar fran biologiskt aktiva blandningar, i synnerhet farmaceutiska beredningar, jemte sett att framstella biologiskt aktiva blandningar med reglerad ....Info
- Publication number
- SE8300577L SE8300577L SE8300577A SE8300577A SE8300577L SE 8300577 L SE8300577 L SE 8300577L SE 8300577 A SE8300577 A SE 8300577A SE 8300577 A SE8300577 A SE 8300577A SE 8300577 L SE8300577 L SE 8300577L
- Authority
- SE
- Sweden
- Prior art keywords
- biologically active
- regulated
- water
- coating
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (2)
1. FOrfarande far framstallnIng av biologiskt aktiva kompositioner, i synnerhet farmaceutiskt aktiva kompositioner med kontrollerad frigoring av aktiva bestandsdelar, kannetecknat av att man belagger tabletter eller granuler innehallande den aktiva bestandsdalen med en averdragskomposition, corn innehaller ett vattenolasligt och i mag-tarmsafterna olosligt fllmbildande cellulosaderivat, faretradesv/s cellulosetriacetat eller filmbildande vinylkloridpolymer eller vinylklorid-vinylacetatsampolymer, upplost i ett med vatten joke blandbaxt orgeniskt lasningsmedel eller en blandning av dylika losningsmedel, i vilken polymerlOsning en vattenfas Sr dispexgerad f8r bildning av vatskedroppar med en diameter av upp till ,n4,, fOretrades- vis 1-5 am, varvid vaillp(asen utgar 2, faretradesvis
2. -8% av den totala vuoch vattenopparna inne- hiller 5-30% polyetylenglykol eller glycerol som mjuk- ningsmedel far polymeren och eventuellt 0,05-0,2 mol av en sur eller alkalisk buffert, och att man eventuellt p& averdraget pa i och for sig kAnt satt applicerar ett skikt, cam innehaller en ytterligare aktiv bestandsdel.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU76RI596A HU174057B (hu) | 1976-09-17 | 1976-09-17 | Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8300577D0 SE8300577D0 (sv) | 1983-02-03 |
| SE8300577L true SE8300577L (sv) | 1983-02-03 |
| SE448061B SE448061B (sv) | 1987-01-19 |
Family
ID=11001002
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7710360A SE440025B (sv) | 1976-09-17 | 1977-09-15 | Polymerbaserad overdragskomposition, som tillforsekrar kontrollerad frigoring av aktiva bestandsdelar samt sett att framstella denna |
| SE8300577A SE448061B (sv) | 1976-09-17 | 1983-02-03 | Forfarande for framstellning av farmaceutiskt aktiva kompositioner med kontrollerad frigoring av aktiva bestandsdelar der den aktiva komponenten overdragits med en polymerlosning i vilken en vattenfas er dispergerad |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7710360A SE440025B (sv) | 1976-09-17 | 1977-09-15 | Polymerbaserad overdragskomposition, som tillforsekrar kontrollerad frigoring av aktiva bestandsdelar samt sett att framstella denna |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4267138A (sv) |
| JP (1) | JPS6037093B2 (sv) |
| AT (1) | AT355726B (sv) |
| AU (1) | AU515157B2 (sv) |
| BE (1) | BE858797A (sv) |
| CA (1) | CA1110166A (sv) |
| CH (1) | CH634748A5 (sv) |
| DD (1) | DD137669A5 (sv) |
| DE (1) | DE2741755C2 (sv) |
| DK (1) | DK152831C (sv) |
| ES (1) | ES462418A1 (sv) |
| FI (1) | FI65911C (sv) |
| FR (1) | FR2364660A1 (sv) |
| GB (1) | GB1593062A (sv) |
| HU (1) | HU174057B (sv) |
| IL (1) | IL52936A (sv) |
| NL (1) | NL7710182A (sv) |
| NO (1) | NO148802C (sv) |
| SE (2) | SE440025B (sv) |
| SU (1) | SU1158030A3 (sv) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980000659A1 (en) * | 1978-10-02 | 1980-04-17 | Purdue Research Foundation | Food and pharmaceutical coating composition,method of preparation and products so coated |
| CH647676A5 (fr) * | 1978-12-22 | 1985-02-15 | Donald E Panoz | Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation. |
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| JPS5911563B2 (ja) * | 1980-02-27 | 1984-03-16 | 日本原子力研究所 | 多層構造の徐放性複合体を製造する方法 |
| JPS58157711A (ja) * | 1982-03-12 | 1983-09-19 | Kuraray Co Ltd | 歯面保護用塗布剤 |
| ATE47519T1 (de) * | 1982-07-08 | 1989-11-15 | Leo Ab | Tabletten mit verzoegerter freisetzung sowie verfahren zu deren herstellung. |
| DK151608C (da) * | 1982-08-13 | 1988-06-20 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse |
| JPS59167521A (ja) * | 1983-03-14 | 1984-09-21 | Shin Etsu Chem Co Ltd | 腸溶性コ−テイング剤組成物 |
| JPS59190925A (ja) * | 1983-04-12 | 1984-10-29 | Shin Etsu Chem Co Ltd | 腸溶性コ−テイング剤組成物 |
| US4548990A (en) * | 1983-08-15 | 1985-10-22 | Ciba-Geigy Corporation | Crosslinked, porous polymers for controlled drug delivery |
| US4587069A (en) * | 1983-10-31 | 1986-05-06 | Twinoak Products, Inc. | Process for producing color display means |
| IT1201136B (it) * | 1987-01-13 | 1989-01-27 | Resa Farma | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive |
| GB8707740D0 (en) * | 1987-04-01 | 1987-05-07 | Strathclyde Minerals Ltd | Composition |
| DE3814532A1 (de) * | 1988-04-29 | 1989-11-09 | Bayer Ag | Dhp-retard-zubereitung |
| US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| US5028433A (en) * | 1988-11-30 | 1991-07-02 | Banyu Pharmaceutical Co., Ltd. | Readily absorbable drug formulation of NB-818 |
| ATE118345T1 (de) * | 1990-08-07 | 1995-03-15 | Pfizer | Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen. |
| CA2293793C (en) * | 1997-06-13 | 2006-07-11 | American Home Products Corporation | Rapamycin formulations for oral administration |
| CA2372994C (en) * | 1999-06-04 | 2010-03-23 | Alza Corporation | Implantable gel compositions and method of manufacture |
| JP4644397B2 (ja) * | 2001-09-05 | 2011-03-02 | 信越化学工業株式会社 | 難溶性薬物を含む医薬用固形製剤の製造方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK92805C (da) * | 1959-02-18 | 1962-02-19 | Abbott Lab | Fremgangsmåde til belægning af tabletter og lignende faste medikamenter og flydende blanding til anvendelse ved fremgangsmåden. |
| DK93751C (da) * | 1959-02-18 | 1962-06-25 | Abbott Lab | Fremgangsmåde til overtrækning af tabletter og flydende blanding til brug ved fremgangsmåden. |
| DK100254C (da) * | 1961-06-13 | 1964-11-09 | Abbott Lab | Overtrækningsmiddel til tabletter. |
| US3148124A (en) * | 1962-06-12 | 1964-09-08 | William E Gaunt | Method of preparing sustained release pharmaceutical tablets |
| FR1534254A (fr) * | 1966-08-16 | 1968-07-26 | Phytogen Products | Procédé pour bloquer et favoriser l'oestrus et produit de blocage |
| DE1617351A1 (sv) * | 1967-06-28 | 1972-01-05 | ||
| SE324859B (sv) * | 1967-09-04 | 1970-06-15 | Ercopharm As | |
| USRE27107E (en) | 1968-05-01 | 1971-03-30 | Drug composition | |
| US3655129A (en) * | 1968-07-17 | 1972-04-11 | Ppg Industries Inc | Slow release films and methods of making same |
| GB1276089A (en) * | 1968-08-23 | 1972-06-01 | Pfizer Ltd | Pharmaceutical preparations |
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| BE791632A (fr) * | 1971-11-20 | 1973-05-21 | Schering Ag | Supports a base de caoutchouc siliconique pour agents medicamenteux |
| GB1425550A (en) * | 1973-04-25 | 1976-02-18 | Alza Corp | Device for releasing active agent and process for producing the same |
| US3923939A (en) * | 1974-06-07 | 1975-12-02 | Alza Corp | Process for improving release kinetics of a monolithic drug delivery device |
| US3946106A (en) * | 1974-10-24 | 1976-03-23 | G. D. Searle & Co. | Microsealed pharmaceutical delivery device |
-
1976
- 1976-09-17 HU HU76RI596A patent/HU174057B/hu not_active IP Right Cessation
-
1977
- 1977-09-14 AU AU28780/77A patent/AU515157B2/en not_active Expired
- 1977-09-15 IL IL52936A patent/IL52936A/xx unknown
- 1977-09-15 FI FI772719A patent/FI65911C/fi not_active IP Right Cessation
- 1977-09-15 SE SE7710360A patent/SE440025B/sv not_active IP Right Cessation
- 1977-09-15 DK DK409177A patent/DK152831C/da not_active IP Right Cessation
- 1977-09-16 FR FR7728038A patent/FR2364660A1/fr active Granted
- 1977-09-16 CH CH1135777A patent/CH634748A5/de not_active IP Right Cessation
- 1977-09-16 NL NL7710182A patent/NL7710182A/xx not_active Application Discontinuation
- 1977-09-16 SU SU772524795A patent/SU1158030A3/ru active
- 1977-09-16 BE BE180987A patent/BE858797A/xx not_active IP Right Cessation
- 1977-09-16 ES ES462418A patent/ES462418A1/es not_active Expired
- 1977-09-16 GB GB38636/77A patent/GB1593062A/en not_active Expired
- 1977-09-16 NO NO773187A patent/NO148802C/no unknown
- 1977-09-16 DE DE2741755A patent/DE2741755C2/de not_active Expired
- 1977-09-16 AT AT665877A patent/AT355726B/de not_active IP Right Cessation
- 1977-09-17 JP JP52111262A patent/JPS6037093B2/ja not_active Expired
- 1977-09-19 CA CA286,958A patent/CA1110166A/en not_active Expired
- 1977-09-19 DD DD77201092A patent/DD137669A5/xx not_active IP Right Cessation
- 1977-09-19 US US05/834,492 patent/US4267138A/en not_active Expired - Lifetime
-
1983
- 1983-02-03 SE SE8300577A patent/SE448061B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU515157B2 (en) | 1981-03-19 |
| BE858797A (fr) | 1978-01-16 |
| SE440025B (sv) | 1985-07-15 |
| ATA665877A (de) | 1979-08-15 |
| IL52936A0 (en) | 1977-11-30 |
| CH634748A5 (de) | 1983-02-28 |
| NO148802B (no) | 1983-09-12 |
| FI772719A7 (fi) | 1978-03-18 |
| FR2364660A1 (fr) | 1978-04-14 |
| NO148802C (no) | 1983-12-21 |
| HU174057B (hu) | 1979-10-28 |
| DE2741755A1 (de) | 1978-03-23 |
| DD137669A5 (de) | 1979-09-19 |
| US4267138A (en) | 1981-05-12 |
| IL52936A (en) | 1981-06-29 |
| NO773187L (no) | 1978-03-20 |
| FI65911C (fi) | 1984-08-10 |
| ES462418A1 (es) | 1978-12-01 |
| JPS6037093B2 (ja) | 1985-08-24 |
| DE2741755C2 (de) | 1986-09-25 |
| NL7710182A (nl) | 1978-03-21 |
| SE8300577D0 (sv) | 1983-02-03 |
| JPS5362822A (en) | 1978-06-05 |
| DK152831C (da) | 1988-11-07 |
| AU2878077A (en) | 1979-03-22 |
| SE448061B (sv) | 1987-01-19 |
| FR2364660B1 (sv) | 1982-12-10 |
| CA1110166A (en) | 1981-10-06 |
| AT355726B (de) | 1980-03-25 |
| DK152831B (da) | 1988-05-24 |
| GB1593062A (en) | 1981-07-15 |
| SU1158030A3 (ru) | 1985-05-23 |
| DK409177A (da) | 1978-03-18 |
| FI65911B (fi) | 1984-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8300577L (sv) | Overdrag som tillforsekrar reglerad avgivning av akriva bestandsdelar fran biologiskt aktiva blandningar, i synnerhet farmaceutiska beredningar, jemte sett att framstella biologiskt aktiva blandningar med reglerad .... | |
| EP0173928B1 (en) | Controlled-release medical preparations | |
| US5178868A (en) | Dosage form | |
| US5149542A (en) | Coating membrane and compositions prepared therefrom | |
| EP0086093B1 (en) | Long-lasting three layered pharmaceutical film preparations | |
| FI121620B (sv) | Förfarande för att erhålla en formulation med kontrollerad frigöring av ett aktivt ämne | |
| JP3174285B2 (ja) | セチリジンおよびプソイドエフェドリンを含む固体剤形およびその製造方法 | |
| EP0171457A1 (en) | Composition for the controlled discharge of an active ingredient, and its preparation | |
| HU201469B (en) | Process for producing orally administrable composition with osmotic dosing, comprising metoprolol salt | |
| PT711146E (pt) | Dispositivos osmoticos com revestimentos permeaveis ao vapor | |
| EP0211991B1 (en) | Substained release tablets and method for preparation thereof | |
| CA2000932C (en) | Oral pharmaceutical controlled release multiple unit dosage form | |
| EP0662832A1 (en) | Oral compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime | |
| JPS58116414A (ja) | ニカルジピン持続性製剤用球形顆粒およびその製造法 | |
| Muhammad et al. | Modifying the release properties of Eudragit® L30D | |
| JP2001131059A (ja) | 多細孔性食物防護 | |
| JP2567427B2 (ja) | 浸透分配経口投与製剤 | |
| KR900011455A (ko) | 활성제의 서방형 제제 및 그 제조방법 | |
| FI102455B (sv) | Förfarande för framställning av en oral farmaceutisk flerenhetsformule ring | |
| KR930003113B1 (ko) | 서방성 코팅 정제의 제조방법 | |
| Aboutaleb et al. | FORMULATION AND EVALUATION OF TETRACAINE HYDROCHLORIDE POLYMERIC FILMS FOR TOPICAL APPLICATION | |
| KR20040105182A (ko) | 난용성 약물의 서방형 정제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8300577-7 Effective date: 19920408 Format of ref document f/p: F |